Market Authorization Validity and Re-registration in Ethiopia

1. Key takeaways

The market authorization (MA) certificate issued by EFDA is valid for 5 years and must be renewed every 5 years through re-registration. The application window for re-registration opens when 3 months remain before certificate expiry; the authority explicitly advises applicants to submit at least 2 months before expiry, because the evaluation of a re-registration application also takes time. If the MA certificate has already expired before the re-registration application is submitted, the applicant must proceed through a new application, with requirements and review duration identical to those for a first-time product registration. Re-registration requires eight sets of documentation (items a–h), ranging from the cover letter and quality management system certificate to change summaries and post-market reports. The window mechanics, the expiry consequence and the document list together define the renewal calendar, and misreading any one of them converts a routine renewal into a full re-entry project.

2. Legal basis

3. Expert insights

Insight 1: The 3-month window opening and the 2-month submission advice are two different gates, the first systemic and the second advisory.

Section 12.1 states that the re-registration option is opened when 3 months remain before MA certificate expiry, and separately advises applicants to submit at least 2 months before expiry. Reading the two as a single deadline produces two classic failures: companies that file the moment the window opens without having reserved evaluation time, and companies that assume any filing within the final 3 months is timely. The window is a system gate; the 2-month mark is the authority’s own risk buffer for review duration, and treating it as binding is the safer reading.

Insight 2: The cost of missing the deadline is not a fine, it is going back to the starting line.

Section 12.1 provides that where the MA certificate has already expired before the re-registration application is submitted, a new application must be filed, with registration requirements and evaluation duration identical to those for a new product registration. After expiry, the applicant must pass through screening and evaluation again, pay again (screening at 350 Birr plus evaluation at 1300 Birr, rather than the re-registration fee of 870 Birr), and absorb the full review cycle once more. During the entire gap the product cannot lawfully be supplied, so commercial continuity depends entirely on filing inside the window.

Insight 3: The core of the re-registration document list is not resubmission but proving that nothing changed, or explaining what did.

Item (g) requires either a no-change confirmation letter or a summary of changes since the most recent EFDA approval. This provision links re-registration to the post-approval change notification regime: if changes made over the past 5 years were not notified and approved as required, the no-change confirmation letter cannot be truthfully issued, and the re-registration itself will expose the compliance gap. The list therefore functions as a five-year audit checkpoint.

Insight 4: Vigilance and post-market surveillance reports are explicitly bound to product attributes.

Item (h) requires device vigilance and post-market surveillance reports for sterile devices, devices with a measuring function, and all Class III / Class C and above devices. This sub-item confirms that re-registration is not a purely documentary renewal: high-risk and attribute-flagged products must show substantive post-market data accumulation. Companies holding such products should treat the five-year cycle as the outer boundary of an ongoing reporting obligation, not as the moment to start compiling data.

4. Practical recommendations

1. Set a two-node early warning: start document preparation 4 months before expiry, file as soon as the window opens at 3 months, and never later than 2 months before expiry.
2. Reconcile the change ledger first: compare every design, material, process, label and manufacturer-information change made over the past 5 years, and confirm each was notified and approved.
3. Prepare all eight items (a)–(h): cover letter in the Annex III format, QMS certificate, free sale certificate or foreign MA certificate, manufacturing license, declaration of conformity in the Annex VI format, GMP certificate where applicable, no-change confirmation letter or change summary, and vigilance and PMS reports where applicable.
4. Check certificate validity dates first: QMS, FSC and GMP certificates must be valid, authentic and originals at submission; any close to expiry should be renewed abroad first.
5. Budget the re-registration fee at 870 Birr, and keep a reserve for a possible laboratory testing trigger at 200 USD.
6. Keep evidence of the submission date: the filing date determines both window compliance and the expiry analysis, so retain system confirmations.

5. Verification checklist

• □ Confirmed that the MA is valid for 5 years and an expiry alert has been set
• □ Submitted after the window opened at 3 months before expiry
• □ Submission made no later than 2 months before expiry
• □ The certificate has not expired (an expired certificate requires a new application)
• □ All eight re-registration items (a)–(h) have been assembled
• □ Vigilance and PMS reports attached for high-risk / sterile / measuring-function products
• □ The change ledger has been reconciled with no un-notified changes
• □ The re-registration evaluation fee of 870 Birr has been paid

Regulatory information verified as of October 29, 2026. The validity period, re-registration window and eight-item documentation requirements listed in this article are governed by the current text of Section 12.1 of the fourth edition of EFDA-GDL-046; when the guideline is revised, the provisions must be re-checked.

Local resource in Ethiopia: GRZAN supports manufacturers from the Chinese mainland and overseas in engaging with the Ethiopian Food and Drug Authority (EFDA) on market authorization (MA), Certificate of Competence (CoC) and import permit applications, including local agent structuring and agency agreement review, SRA reliance pathway justification, UMDN coding and classification determination, technical documentation preparation, and the establishment of vigilance and post-market surveillance systems. Service capabilities cover product attribute determination and risk classification (non-IVD Class I–IV / IVD Class A–D), market authorization applications and re-registration, applicability assessment for the low-risk notification procedure, Essential Principles conformity reasoning, label and instruction-for-use localization in English, and vigilance reporting with field safety corrective action support. Contact: hito.lin@grzan.cn; website www.grzan.cn. For re-registration planning, change-ledger reconciliation and local authorized representative support in the Ethiopian market, GRZAN can also be reached at info@grzanglobal.com.